Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2012
04/26/2012US20120100074 Humanized antibodies against light and uses thereof
04/26/2012US20120100068 Anti-CD74 Immunoconjugates and Methods of Use
04/26/2012US20120100067 Solubilisation Method
04/26/2012DE102010049595A1 Chinazolinderivate Quinazoline derivatives
04/26/2012CA2818662A1 Nucleic acid molecule inducing rna interference, and uses thereof
04/26/2012CA2815363A1 Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mtor pathway
04/26/2012CA2815127A1 Quinoxaline derivatives
04/26/2012CA2815102A1 Wdhd1 peptides and vaccines including the same
04/26/2012CA2815080A1 Anti-folate receptor alpha antibody glycoforms
04/26/2012CA2815041A1 Antibodies
04/26/2012CA2814594A1 Tetrahydroquinoline derivatives used as ampk activators
04/26/2012CA2814581A1 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
04/26/2012CA2813796A1 Erbb3 binding antibody
04/26/2012CA2813063A1 Antagonist for mutated androgen receptor
04/26/2012CA2812320A1 Pochoxime conjugates useful for the treatment of hsp90 related pathologies
04/26/2012CA2811171A1 Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors
04/25/2012EP2444912A2 Magnetic drug, magnetic drug guidance system and magnetic drug design method
04/25/2012EP2444411A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
04/25/2012EP2444402A1 Compound having spiro-bonded cyclic group and use thereof
04/25/2012EP2444088A1 Amino derivatives for the treatment of proliferative skin disorders
04/25/2012EP2444085A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer
04/25/2012EP2444082A2 Hydroxymethylbutyrate compositions and uses thereof
04/25/2012EP2443929A1 Inhibitors of Bruton's Tyrosine Kinase
04/25/2012EP2443257A1 Method of determining response to treatment with immunomodulatory composition
04/25/2012EP2443150A2 Anti-vegf antibodies and their uses
04/25/2012EP2443125A2 Camptothecin derivatives
04/25/2012EP2443117A1 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
04/25/2012EP2443116A1 Thiadiazole derivatives and their use for the treatment of disorders mediated by slpl receptors
04/25/2012EP2443104A1 Disubstituted phthalazine hedgehog pathway antagonists
04/25/2012EP2443103A1 Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb)
04/25/2012EP2443099A1 Antifungal 1, 2, 4-triazolyl derivatives having a 5- sulfur substituent
04/25/2012EP2443098A1 Antifungal 1, 2, 4-triazolyl derivatives
04/25/2012EP2443097A1 Antifungal 1, 2, 4-triazolyl derivatives
04/25/2012EP2442815A2 Sox11 activating agents and uses thereof
04/25/2012EP2442800A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
04/25/2012EP2279187B1 Spirocyclic derivatives as histone deacetylase inhibitors
04/25/2012EP2084147B1 Heterocyclic fxr binding compounds
04/25/2012EP2013207B1 Imidazo[4,5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
04/25/2012EP1984333B1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
04/25/2012EP1909600B1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
04/25/2012EP1888578B9 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo [4,5-c] quinolinyl)-phenyl]propionitrile as lipid kinase inhibitor
04/25/2012EP1879656B1 Pharmaceutical composition comprising an antitumoral agent and an active agent selected especially among carveol, thymol and carvacrol
04/25/2012EP1848442B1 2-methylene-19-nor-(20s-24epi)-1alpha,25-dihydroxyvitamine-d2
04/25/2012EP1732536B1 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
04/25/2012EP1716173B1 Carcinoembryonic antigen fusion protein and uses thereof
04/25/2012EP1650205B1 Cyclohexanecarboxylic acid compound
04/25/2012EP1505993B1 Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
04/25/2012EP1482933B1 Potent, simplified derivatives of immunosuppressive agents
04/25/2012EP1416970B1 Conjugate
04/25/2012EP1383490B1 Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
04/25/2012EP1381432B9 HSA-free formulations of interferon-beta
04/25/2012EP1112084B2 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
04/25/2012EP1014953B1 Formulations for hydrophobic pharmaceutical agents
04/25/2012CN1953762B Gst活化的抗癌化合物在制备改善铂类化合物的抗癌副作用的药物中的用途 Gst-activated anticancer compound in the preparation of the platinum compounds to improve the side effect of anticancer drugs in use
04/25/2012CN1950521B Granulin-epithelin precursor (GEP) as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
04/25/2012CN1921878B 属于Bcl-2家族的蛋白和其片段,和它们在癌症患者中的用途 Belonging to the Bcl-2 family of proteins and their fragments, and their use in cancer patients
04/25/2012CN1805758B Nucleotide and cellular vaccine composition
04/25/2012CN1578688B Method and apparatus for the photomodulation of living cells
04/25/2012CN102428179A 用于增强t细胞功能的方法 Methods for enhancing the t-cell function
04/25/2012CN102428102A 诱导XAGE-1b特异性免疫反应的肽及其利用 XAGE-1b induced peptide-specific immune responses and their use
04/25/2012CN102428098A Novel solid materials of {[2s, 5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
04/25/2012CN102428087A 用作激酶抑制剂的咪唑并吡嗪类化合物 Useful as kinase inhibitors imidazopyrazine compounds
04/25/2012CN102428086A Cdk抑制剂的盐类 Cdk inhibitors salts
04/25/2012CN102428085A 作为激酶抑制剂的嘧啶取代的嘌呤化合物 As kinase inhibitors substituted purine pyrimidine compounds
04/25/2012CN102428084A 化合物 Compound
04/25/2012CN102428079A Imidazolidine-2,4-dione derivatives and use thereof as a medicament
04/25/2012CN102428073A 咪唑烷-2,4-二酮衍生物及其作为癌症药物的用途 Imidazolidine-2,4-dione derivatives and their use as a medicament for cancer
04/25/2012CN102427853A Protease Inhibitors
04/25/2012CN102427814A 激酶蛋白结合抑制剂 Kinase protein binding inhibitors
04/25/2012CN102427808A 基于作为细胞因子活性的活化剂或抑制剂的硫酸化透明质酸的新的用于局部应用的药剂 New medicament for topical application based on the activity of cytokines as activators or inhibitors of the sulfated hyaluronic acid
04/25/2012CN102424818A Caspase-1-ES cell line induced by mifepristone
04/25/2012CN102424699A 一种新灰毡毛忍冬皂苷及其制备方法和用途 A new macranthoides saponins and its preparation and use
04/25/2012CN102424696A Shikonin amino deoxy glycosides and application thereof in preparation of antitumor medicines
04/25/2012CN102424693A 四-2,6-吡啶二羧酸-二-（二茂铁双甲酸）三苯基锡配合物及其制备方法与应用 Four pyridine-2,6-dicarboxylic acid - two - and its preparation method and application (ferrocene double formic acid) triphenyltin complexes
04/25/2012CN102424683A 一种藤黄酸氨基醇酯类化合物、其制备方法及医药用途 One kind of Garcinia acid amino alcohol esters, their preparation and pharmaceutical use
04/25/2012CN102424681A Acyl-tetrahydro-beta-carboline compound as well as derivatives, application and preparation method thereof
04/25/2012CN102424657A 用于癌症治疗的新型三氮烯化合物 The new triazene compounds for cancer treatment
04/25/2012CN102423507A 一种放射性核素标记的载药生物高分子纳米纤维膜、制备方法及其用途 Drug biopolymer radionuclide labeled nanofiber membrane preparation method and use thereof
04/25/2012CN102423493A 一种可高效高特异灭杀乳腺癌细胞的药物 One kind can efficiently kill human breast cancer cells highly specific drug
04/25/2012CN102423492A 一种莱菔硫烷的包合物及其制备方法 One kind of inclusion compound sulforaphane and its preparation method
04/25/2012CN102423491A 一种聚胺型两亲嵌段聚电解质在制备药物载体中的应用 An amphiphilic block polyamine type polyelectrolyte used in the preparation of the drug carrier
04/25/2012CN102423489A 组织蛋白酶l抑制剂在制备放疗增敏药物中的应用 Cathepsin inhibitors in the preparation of l radiosensitization drug application
04/25/2012CN102423486A 肽康灵食品配药配方 Peptide Kang Ling food dispensing recipe
04/25/2012CN102423484A 一种稳定的西曲瑞克药物组合物及其制备方法 Cetrorelix a stable pharmaceutical composition and its preparation method
04/25/2012CN102423438A 一种用于抗癌的双组方药物及其制备方法 Double prescription drugs and their preparation method for cancer
04/25/2012CN102423416A 一种预防或治疗胃癌的药物组合物 A method for preventing or treating gastric cancer pharmaceutical composition
04/25/2012CN102423384A 一种治疗肺癌的中药制剂及其制备方法 A Chinese medicine treatment of lung cancer and its preparation method
04/25/2012CN102423369A 一种预防或治疗卵巢癌的中药组合物 A method of preventing or treating ovarian cancer medicine composition
04/25/2012CN102423321A 从千层塔滤渣中提取总黄酮的方法 Residue extracted from Melaleuca tower method of total flavonoids
04/25/2012CN102423316A 一种紫杉醇复方制剂及其制备方法 A COMPOUND Taxol and its preparation method
04/25/2012CN102423307A 去氢厄弗酚在制备抗肿瘤及抑制肿瘤新生血管生成药物、保健食品或化妆品中的应用 Dehydroepiandrosterone Ephesus phenol in the preparation of anti-tumor and inhibit tumor angiogenesis drugs, health food or cosmetics applications
04/25/2012CN102423302A 载鬼臼苦素纳米胶束制剂和冻干制剂及其制备方法 Upload picropodophyllin micelle formulations and lyophilized formulation and preparation method
04/25/2012CN102423301A 紫杉醇纳米胶束的制备方法 Preparation of paclitaxel micelles
04/25/2012CN102423299A Preparation method for novel drug-loaded chitosan nano-microspheres
04/25/2012CN102153551B 基于吲唑或氮杂吲唑的双芳基脲或硫脲类结构抗肿瘤药物 Bis-aryl urea or thiourea-based structure antineoplastic or aza-indazole indazole
04/25/2012CN102106909B 一种扶正增效的抗癌中草药及制备方法 A synergistic anticancer herbs and preparation of righting
04/25/2012CN102051016B 可降解的双亲性三嵌段共聚物胶束及其制备方法和用途 Biodegradable amphiphilic triblock copolymer micelles and their preparation and use
04/25/2012CN101991636B 艾迪注射制剂的检测方法 Eddie injectable formulations of detection methods
04/25/2012CN101974076B 抑制由碱性成纤维细胞生长因子诱导的细胞增殖及血管增生的环肽 Inhibition by basic fibroblast growth factor-induced cell proliferation and angiogenesis cyclic peptide
04/25/2012CN101891794B 一种具有抗肿瘤活性的熊果酸哌嗪类衍生物及其制备方法 Ursolic acid piperazine derivatives and method for preparing anti-tumor activity
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 2211